SCI Abstract

search
+
Research progress and development strategies of antibody-oligonucleotide conjugates
Research progress and development strategies of antibody-oligonucleotide conjugates
Antibody-oligonucleotide conjugates (AOCs) effectively integrate the delivery capability of antibodies with the specific g...
Characterization of CAR-T cell factors that contribute to myeloid cell activation
Characterization of CAR-T cell factors that contribute to myeloid cell activation
Chimeric antigen receptor (CAR) T cell therapies have shown remarkable success in the treatment of hematologic cancers; ho...
DOCTER: a genetically encoded switchable protein module for ERα-mediated transcriptional regulation
DOCTER: a genetically encoded switchable protein module for ERα-mediated transcriptional regulation
The inhibition of estrogen receptor (ER)-mediated genomic signaling in ER-positive cancer cells has long been a primary fo...
Environmental and developmental factors shape anti-AAV immunity in pigs
Environmental and developmental factors shape anti-AAV immunity in pigs
Use of adeno-associated virus (AAV) vectors has revolutionized in vivo gene therapy, but the presence of pre-existing neut...
AAV8-mediated mouse/human PROC expression rescues thrombophilia in hereditary protein C-deficient mice
AAV8-mediated mouse/human PROC expression rescues thrombophilia in hereditary protein C-deficient mice
Hereditary protein C (PC) deficiency, which is caused by PROC gene mutations, increases the risk of venous thromboembolism...
High resolution ES-DMA quantifies AAV capsid DNA content by electrical mobility to mass correlation
High resolution ES-DMA quantifies AAV capsid DNA content by electrical mobility to mass correlation
Recombinant Adeno-Associated Virus (rAAV) is the leading viral vector platform for gene therapy. A persistent challenge in...
Applications of genome editing technologies in the treatment of human diseases
Applications of genome editing technologies in the treatment of human diseases
Genome editing has progressed from a laboratory capability for targeted DNA manipulation to a clinically relevant strategy...
Assessment of F/HN-pseudotyped lentiviral vector following intravenous delivery to mice
Assessment of F/HN-pseudotyped lentiviral vector following intravenous delivery to mice
In pursuit of a gene transfer agent with efficient pulmonary transduction, the UK Respiratory Gene Therapy Consortium has ...
Focused ultrasound widely broadens AAV-delivered Cas9 distribution and activity
Focused ultrasound widely broadens AAV-delivered Cas9 distribution and activity
Because children have little temporal exposure to environment and aging, most pediatric neurological diseases are inherent...
A peptide conjugate enables systemic injection of the morpholino inducer and more durable induction of T3H38 ribozyme-controlled AAV transgene in mice
A peptide conjugate enables systemic injection of the morpholino inducer and more durable induction of T3H38 ribozyme-controlled AAV transgene in mice
Genetic switches that allow for precise control over transgene expression timing or levels may improve the safety and expa...
AAV1.NT3 gene therapy mitigates the severity of autoimmune encephalomyelitis in the mouse model for multiple sclerosis
AAV1.NT3 gene therapy mitigates the severity of autoimmune encephalomyelitis in the mouse model for multiple sclerosis
Multiple sclerosis (MS) is an immune-mediated chronic inflammatory and neurodegenerative disease of the central nervous sy...
A capless hairpin-protected mRNA vaccine encoding the full-length Influenza A hemagglutinin protects mice against a lethal Influenza A infection
A capless hairpin-protected mRNA vaccine encoding the full-length Influenza A hemagglutinin protects mice against a lethal Influenza A infection
The success of mRNA vaccines in controlling the COVID 19 pandemic has confirmed the efficacy of synthetically synthesized ...
Improved induction of ribozyme-controlled AAV transgene via peptide-conjugated morpholino oligos
Improved induction of ribozyme-controlled AAV transgene via peptide-conjugated morpholino oligos
Adeno-associated virus (AAV)-mediated transgene delivery has emerged as a cornerstone in the field of gene therapy [1, 2]....
AAV vector engineering for human aorta transduction: becoming a smooth operator
Zhuge Y, Zhang J, Qian F, Wen Z, Niu C, Xu K, et al. Role of smooth muscle cells in Cardiovascular Disease. Int J Biol Sci...
AAV-based gene replacement therapy prevents and halts manifestation of abnormal neurological phenotypes in a novel mouse model of PMM2-CDG
AAV-based gene replacement therapy prevents and halts manifestation of abnormal neurological phenotypes in a novel mouse model of PMM2-CDG
Inherited Phosphomannomutase 2 (PMM2) deficiency, also known as PMM2-CDG, is the most prevalent N-linked congenital disord...
CRISPR targeting of SNPs associated with age-related macular degeneration in ARPE-19 cells: a potential model for manipulating the complement system
CRISPR targeting of SNPs associated with age-related macular degeneration in ARPE-19 cells: a potential model for manipulating the complement system
Age-related Macular degeneration (AMD) is a major cause of vision loss and is linked to several predisposing single nucleo...
Engineered compact pan-neuronal promoter from Alphaherpesvirus LAP2 enhances target gene expression in the mouse brain and reduces tropism in the liver
Engineered compact pan-neuronal promoter from Alphaherpesvirus LAP2 enhances target gene expression in the mouse brain and reduces tropism in the liver
Small promoters capable of driving potent neuron-restricted gene expression are required to support successful brain circu...
Looking ahead: ethical and social challenges of somatic gene therapy for sickle cell disease in Africa
Somatic gene therapy will be one of the most exciting practices of genetic medicine in Africa and is primed to offer a ...
Modeling Glutaric Aciduria Type I in human neuroblastoma cells recapitulates neuronal damage that can be rescued by gene replacement
Modeling Glutaric Aciduria Type I in human neuroblastoma cells recapitulates neuronal damage that can be rescued by gene replacement
Glutaric Aciduria type I (GA1) is a rare neurometabolic disorder caused by mutations in the GDCH gene encoding for glutary...
Towards affordable CRISPR genomic therapies: a task force convened by the Innovative Genomics Institute
Towards affordable CRISPR genomic therapies: a task force convened by the Innovative Genomics Institute
To the best of our knowledge, this effort represents the most comprehensive attempt to understand and develop solutions to...
Overexpression of KCNN4 channels in principal neurons produces an anti-seizure effect without reducing their coding ability
Overexpression of KCNN4 channels in principal neurons produces an anti-seizure effect without reducing their coding ability
Gene therapy offers a potential alternative to the surgical treatment of epilepsy, which affects millions of people and is...
Implications of maternal-fetal health on perinatal stem cell banking
Implications of maternal-fetal health on perinatal stem cell banking
Cell based therapies are being assessed for their therapeutic potential across a variety of diseases. Gestational tissues ...
A practical approach for adoption of a hub and spoke model for cell and gene therapies in low- and middle-income countries: framework and case studies
A practical approach for adoption of a hub and spoke model for cell and gene therapies in low- and middle-income countries: framework and case studies
In the rapidly evolving landscape of biotechnologies, cell and gene therapies are being developed and adopted at an unprec...
Cost of gene therapy
Since its earliest days and during the ensuing 5–6 decades, the field of human gene therapy has been char...
Approval and therapeutic value of gene therapies in the US and Europe
Gene therapies are a fast-growing area of innovation and hold promise for the treatment of many diseases currently with un...
Access to affordable medicines: obligations of universities and academic medical centers
The authors thank Katharine Gleason, MPH and Mariah Johnson, MPH for research assistance and administrative support. The a...
Successes and challenges in clinical gene therapy
Despite the ups and downs in the field over three decades, the science of gene therapy has continued to advance and provid...
The estimated annual financial impact of gene therapy in the United States
The estimated annual financial impact of gene therapy in the United States
Gene therapy is a new class of medical treatment that alters part of a patient’s genome through the replacement, del...
Prednisolone and rapamycin reduce the plasma cell gene signature and may improve AAV gene therapy in cynomolgus macaques
Prednisolone and rapamycin reduce the plasma cell gene signature and may improve AAV gene therapy in cynomolgus macaques
Adeno-associated virus (AAV) vector gene therapy is a promising approach to treat rare genetic diseases; however, an ongoi...
p53 dry gene powder enhances anti-cancer effects of chemotherapy against malignant pleural mesothelioma
p53 dry gene powder enhances anti-cancer effects of chemotherapy against malignant pleural mesothelioma
Dry gene powder is a novel non-viral gene-delivery system, which is inhalable with high gene expression. Previously, we sh...
Load More
format_indent_increase